Dr. Mélèze HOCINI, MD, is an Associate Professor at Bordeaux University Hospital, Department of Cardiac arrhythmias center in Bordeaux, France. She has more than 20 years of experience in catheter ablation procedures, including atrial fibrillation ablation and ablation of ventricular fibrillation (VF). Her research interests focus on the mechanisms of atrial rhythm disorders and their treatment, as well as mapping and treatment of ventricular fibrillation and evaluation of patients at risk of sudden cardiac death.
After graduating in medicine in 1996, she went on to specialize in cardiac electrophysiology and started off with research on the electrophysiological properties of the pulmonary veins in large animal models and in patients. She has been strongly involved in the development and evaluation of several innovative therapeutic strategies in atrial fibrillation. Some discoveries led to the development of a curative treatment recommended by international guidelines currently benefiting several millions of thousands of patients every year worldwide. She has also a keen interest in lethal ventricular arrhythmias, particularly ventricular fibrillation in different patient populations (IVF, J wave syndromes, ischemic VF, and VF in the setting of hypertrophic cardiomyopathy).
Dr. Hocini has been an invited lecturer to numerous international conferences and has published over 400 peer-reviewed research articles in high-profile journals such as the New England Journal of Medicine, Lancet, JAMA, Circulation, JACC, PACE, and Nature Reviews. She has authored multiple chapters in medical textbooks related to her specialty interest and published numerous abstracts.
Dr. Hocini has mentored many international students, PhDs, and research fellows who first authored peer-reviewed original research papers in some of the top journals in the field of cardiac electrical disorders.
Finally, in 2010, she was part of the team involved in the creation of the research institute Liryc (Electrophysiology and Heart Modeling Institute) of which she has been the Deputy Director since 2013, bringing her new administrative and scientific responsibilities. More recently, she has taken up the role of Director of the Liryc fundraising campaign in order to improve innovation, inform people, and raise their awareness about the cardiac electrical disease.